title: The use of nitrates in the prevention of contrast-induced nephropathy in patients hospitalized after undergoing percutaneous coronary intervention.
abstract: Contrast-induced nephropathy (CIN) is a significant cause of morbidity and mortality and effective strategies for its prevention are greatly needed. The purpose of this retrospective, single-center study was to investigate whether nitrate use during percutaneous coronary artery intervention reduces the incidence of CIN. Chart review of all individuals who underwent percutaneous coronary intervention (PCI) from April 2010 to March 2011 was done. Included in the study were patients who were admitted to the hospital after percutaneous coronary artery intervention and had baseline and follow-up creatinine measured. Patients with end-stage renal disease requiring dialysis and those patients with insufficient information to calculate Mehran score were excluded. There were 199 patients who met the eligibility criteria for inclusion in this study. In the identified population, postprocedure renal function was compared between 112 patients who received nitrates prior to coronary intervention and 87 who did not. Baseline characteristics were similar between the 2 groups. Contrast-induced nephropathy was defined as either a 25% or a 0.5 mg/dL, or greater, increase in serum creatinine during the first 48 to 72 hours after contrast exposure. Overall, 43 (21.6%) patients developed CIN post-PCI. Of the patients who received nitrates, 15.2% developed renal impairment when compared to 29.9% in those who did not (odds ratio [OR] = 0.42, 95% confidence interval [CI] 0.21-0.84, P = .014). Multivariate logistic regression analysis demonstrated that nitrate use was independently correlated with a reduction in the development of contrast nephropathy (OR = 0.334, 95% CI 0.157-0.709, P = .004). Additionally, of the various methods of nitrate administration, intravenous infusion was shown to be the most efficacious route in preventing renal impairment (OR = 0.42, 95% CI 0.20-0.90, P = .03). In conclusion, the use of nitrates prior to PCI, particularly intravenous nitroglycerin infusion, may be associated with a decreased incidence of CIN.
authors.affiliation: 1Division of Cardiology, Columbia University, Mount Sinai Heart Institute, Miami Beach, FL, USA.
authors.forename: Julio G
authors.initials: JG
authors.lastname: Peguero
authors.forename: Vertilio
authors.initials: V
authors.lastname: Cornielle
authors.forename: Sabas I
authors.initials: SI
authors.lastname: Gomez
authors.forename: Omar M
authors.initials: OM
authors.lastname: Issa
authors.forename: Todd B
authors.initials: TB
authors.lastname: Heimowitz
authors.forename: Orlando
authors.initials: O
authors.lastname: Santana
authors.forename: Robert C
authors.initials: RC
authors.lastname: Goldszer
authors.forename: Gervasio A
authors.initials: GA
authors.lastname: Lamas
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000517:prevention & control*; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009566:Nitrates / Q000008:administration & dosage*; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D012189:Retrospective Studies
chemical_list: D003287:Contrast Media; D009566:Nitrates
keywords: contrast-induced nephropathy; nitrates; prevention